Efficacy and Safety of Anti-Interleukin-5 Therapy in Patients with Asthma: A Systematic Review and Meta-Analysis. - Wikidata - wikimedia - TriplyDB

Efficacy and Safety of Anti-Interleukin-5 Therapy in Patients with Asthma: A Systematic Review and Meta-Analysis.

Efficacy and Safety of Anti-Interleukin-5 Therapy in Patients with Asthma: A Systematic Review and Meta-Analysis.

http://www.wikidata.org/entity/Q36201117

about

Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects.Clinical management of severe therapy-resistant asthma.Short-term efficacy and tolerability of venlafaxine extended release in adults with generalized anxiety disorder without depression: A meta-analysis.Anti-IL5 therapies for asthma.Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma.Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma.Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis.Health care resource utilization and characteristics of patients with eosinophilic asthma in secondary health care in Finland.Resolution of chronic inflammatory disease: universal and tissue-specific concepts

P2860

Q38661881-6BCA64A4-FFE2-47CA-A790-C56F091A1E4A Q39226704-48A5914A-4AB8-4F99-868A-68ED27F7CDDC Q42370782-E2D203AE-BB58-46BE-8B11-C0966B2B1A8A Q47551081-1F2FC339-27FF-40D6-842E-66217F4285F2 Q47555559-CCE4D179-1586-4297-9B21-D7BA923B2794 Q52571066-B666D791-5504-4617-A06C-59C43948980A Q52646644-3D569944-BBBB-41E1-9456-32D071EAC976 Q55082118-2D8B68E1-1483-4A19-87C4-BA896D111653 Q58778332-5797E77C-0D22-49EF-A8ED-50AE2BC2009A

P2860

Efficacy and Safety of Anti-Interleukin-5 Therapy in Patients with Asthma: A Systematic Review and Meta-Analysis.

http://www.wikidata.org/entity/Q36201117

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Efficacy and Safety of Anti-In ...... atic Review and Meta-Analysis.

@ast

Efficacy and Safety of Anti-In ...... atic Review and Meta-Analysis.

@en

type

label

Efficacy and Safety of Anti-In ...... atic Review and Meta-Analysis.

@ast

Efficacy and Safety of Anti-In ...... atic Review and Meta-Analysis.

@en

prefLabel

Efficacy and Safety of Anti-In ...... atic Review and Meta-Analysis.

@ast

Efficacy and Safety of Anti-In ...... atic Review and Meta-Analysis.

@en

P1433

Q36201117-3CD54770-B881-45DB-967E-4792EF9A8D0B

P1476

Q36201117-5C988027-649C-4DA6-BC0D-B19898607E6C

P2093

Q36201117-79EE1DC5-BF7B-45CF-9DCC-DEA916561ED2

Q36201117-7D9BA465-1617-475F-9A69-16200C8995E5

Q36201117-986D16C1-D990-4C18-9B1E-9358F2841B64

Q36201117-D1C21C00-7D2E-4940-ACE8-39F896E3961F

Q36201117-DEDCE8F1-A3C7-46A8-BE28-F4414F8EE3BD

P275

Q36201117-C5A61CE2-621E-4A04-AFD2-85139882ED28

P2860

Q36201117-01E91626-E234-49DE-A160-9EFD75868C53

Q36201117-022323F0-0F02-442B-B56E-439CA92C5C9B

Q36201117-08C94989-E9EC-4680-937C-636258776033

Q36201117-0DFBE099-FD58-4D33-9862-0CCFFA361E07

Q36201117-11F070A1-CA04-4A64-9564-E758CAF49258

Q36201117-12454576-FCF0-482E-B79A-5A496D9F3BA3

Q36201117-130022D4-F928-40F6-B3AE-CA58BB7AC228

Q36201117-173C2E98-FFC9-4A78-A4DD-F76CC2C39784

Q36201117-1A7DE49A-DA68-4656-B874-01D897DD78B6

Q36201117-1C0A0CC1-BA1C-45EB-939E-66CF75595AC2

P304

Q36201117-FAD87E0F-C4E1-4DE5-9049-260FB4D29E10

P31

Q36201117-914d82c9-3f08-4bf2-8168-6d1d17670404

Q36201117-BF142497-EB9F-4C16-8422-B53E08C59E12

Q36201117-F67AB4ED-4BDE-45B2-802E-7D896E197560

P356

Q36201117-70934424-2575-481C-987F-A55C09E9FE04

P407

Q36201117-DBBC1F9F-895B-4F85-8D50-63961BAD0DAD

P433

Q36201117-828628E8-67F2-4F3B-8801-F78B719C596C

P478

Q36201117-5C77419A-6926-44CE-A16E-301304752E62

P5008

Q36201117-1B90CEC6-12C3-4131-8749-0EAB136747CC

P577

Q36201117-582BBC8E-065C-473B-8165-71662414A5A6

P698

Q36201117-1328E08A-CA35-4D63-92A1-20880FB8F0C5

P921

Q36201117-4DE97B5F-8C52-4428-8838-22BE459B142B

Q36201117-6B56959B-33DC-413D-A7BB-8623FD1BBD45

Q36201117-9821E9A8-411A-4AD6-BA4C-97924BAE543C

Q36201117-9DCD701B-241C-48D1-8628-5888D2ABA572

Q36201117-A6B33CA7-0CBB-41CF-8B53-0457F6320831

Q36201117-F8C7B3AF-2220-4556-963E-F3FB0A17BAE8

P932

Q36201117-E6E32480-4079-4DE2-BA18-FB2E84B7B7B4

P356

JOURNAL.PONE.0166833

P1433

P1476

Efficacy and Safety of Anti-In ...... atic Review and Meta-Analysis.

@en

P2093

Fa-Ping Wang

http://www.w3.org/2001/XMLSchema#string

Hui Mao

http://www.w3.org/2001/XMLSchema#string

Su-Yun Li

http://www.w3.org/2001/XMLSchema#string

Ting Liu

http://www.w3.org/2001/XMLSchema#string

Zhu Lan

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

A re-analysis of the Cochrane Library data: the dangers of unobserved heterogeneity in meta-analyses

Mepolizumab versus placebo for asthma

Bronchial thermoplasty for moderate or severe persistent asthma in adults

Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors

The past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review.

Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease

Emerging therapeutic options for the treatment of patients with symptomatic asthma

Quantifying heterogeneity in a meta-analysis

Reslizumab for Poorly Controlled, Eosinophilic Asthma

The global burden of asthma: executive summary of the GINA Dissemination Committee report

P304

e0166833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0166833

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27875559

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

monoclonal antibody

P932

5119789

http://www.w3.org/2001/XMLSchema#string